Authored By: Sarah
23 Sep 2024

Latest News: Vertebral Augmentation Market 2024-2028: North America Leads Market Growth

Technavio, a leading provider of market research reports, has released its latest study on Vertebral Augmentation Market. This report offers a comprehensive analysis of the current market trends, emerging opportunities, and key challenges. The Vertebral Augmentation Market is poised for growth due to favorable reimbursement scenarios in various regions, particularly in North America. The Affordable Care Act (ACA) and other healthcare innovations in the US have expanded medical insurance coverage, enabling more patients to access minimally invasive procedures such as kyphoplasty and vertebroplasty. These treatments, popular for managing chronic pain in the upper and lower limbs, are increasingly preferred over traditional surgeries. Despite limited reimbursement in countries like Argentina, Brazil, and Mexico, the market is gaining traction due to the proven effectiveness of these devices in treating vertebral compression fractures.

Key Highlights

Growth Projections

The global vertebral augmentation market  size is estimated to grow by USD 568.5 mn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  4.5% during the forecast period. Rising geriatric population is driving market growth, with a trend towards availability of reimbursements  However, availability of alternate medication options  poses a challenge.Key market players include Becton Dickinson and Co., Benvenue Medical Inc., BIOPSYBELL Srl, G21 Srl, Globus Medical Inc., IZI Medical Products, Johnson and Johnson Services Inc., Medtronic Plc, Merit Medical Systems Inc., RONTIS AG, Spine Wave Inc., Stryker Corp., Tecres Spa, Tsunami Medical Srl, and ZAVATION.

Know what is trending in the market - Access a free sample report! 

Major Findings

  • The aging population is a significant driver for the growth of the vertebral augmentation market. With an increasing number of elderly individuals suffering from vertebral compression fractures due to osteoporosis, there is a rising demand for minimally invasive and effective treatments. Vertebral augmentation procedures, such as vertebroplasty and kyphoplasty, offer pain relief and restoration of vertebral height, making them popular choices among geriatric patients. The market for these procedures is expected to expand as the global population ages and the prevalence of vertebral compression fractures increases.

  • The rising prevalence of spine injuries is driving significant growth in the Vertebral Augmentation Market. This minimally invasive procedure, which involves the injection of bone cement into the vertebral body to restore height and strength, is increasingly being adopted for the treatment of vertebral compression fractures. The procedure's ability to reduce pain and improve mobility is making it a preferred choice for patients, leading to a surge in demand. Additionally, the aging population and increasing awareness of spine health are further fueling market expansion.

  • The Vertebral Augmentation Market faces competition from various alternative medication options for the treatment of vertebral compression fractures. These alternatives include pain medication, physical therapy, and minimally invasive spinal fusion procedures. These options may offer relief from pain and discomfort, but they do not address the structural damage caused by the fracture as effectively as vertebral augmentation. However, the availability of these alternatives may impact the market growth and patient decision-making process.

  • The vertebral augmentation market is characterized by the high cost associated with this medical procedure. This expensive treatment option is utilized for the strengthening and stabilization of vertebral bodies, often in the context of vertebral compression fractures. The use of biocompatible materials and advanced techniques contributes to the premium pricing, making it a significant investment for patients and healthcare systems.

Market Research Overview

According to Technavio, the Vertebral Augmentation Market is a significant segment of the expansive Global Healthcare Equipment Market. This market encompasses organizations involved in the research and development (R&D) of various product categories, such as capital equipment, instruments, implants, accessories, and consumables. These products are utilized in the diagnosis, monitoring, and treatment of diverse disease areas. The Global Healthcare Equipment Market's size is determined by the consolidated revenue generated by manufacturers of diagnostic equipment and devices. The healthcare equipment sector is divided into several segments: Devices, which include advanced, differentiated, and clinically tested data-driven devices.

The Vertebral Augmentation Market is experiencing significant growth, fueled by the Rising geriatric population. Businesses are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

For insights on company offerings- Request a sample report!

Regional Insights

The Vertebral Augmentation Market represents a significant growth opportunity for businesses in the orthopedic and neurosurgery sectors. This minimally invasive procedure, which involves the injection of bone cement into vertebral bodies to treat spine fractures and vertebral compression, is gaining traction due to its efficacy and ability to improve patient outcomes. Key market drivers include an aging population, increasing prevalence of spine disorders, and technological advancements. Businesses can capitalize on this trend by offering innovative solutions, enhancing clinical expertise, and expanding their geographical reach.

Research Analysis Overview

The Vertebral Augmentation Market encompasses a range of minimally invasive spinal procedures, including Balloon Kyphoplasty and Vertebroplasty. These procedures are used to treat Spinal Compression Fractures (SCFs) caused by conditions such as Osteoporosis, Ankylosing Spondylitis, Myelomas, Hemangiomas, and Spinal Metastatic Tumors. SCFs can lead to Kyphosis, resulting in difficulty sleeping, decreased lung capacity, loss of independence, depression, and reduced physical activity. Back pain is a common symptom of these conditions. Vertebral Augmentation procedures involve the use of Khphon bone cement or PVA (Polyvinyl Alcohol) Pod Systems to stabilize the vertebral body and restore height. Percutaneous Kyphoplasty (PKP) and Vertebroplasty are the most common vertebral augmentation procedures. These procedures are performed in Ambulatory Surgery Centers and Hospitals. The Kyphoplastic Device and Vertebroplastic Device are used in these procedures. The Kyphoplastic Device includes a balloon that is inflated to restore vertebral height before the bone cement is injected. Vertebroplasty involves the direct injection of bone cement into the vertebral body. Both procedures have shown to improve pain, restore height, and reduce the risk of future fractures. Overall, the Vertebral Augmentation Market is expected to grow due to the increasing prevalence of conditions leading to Spinal Compression Fractures and the benefits of these minimally invasive procedures.

About Technavio                                                                        

Technavio is a global market research company offering comprehensive reports and insights on various industries. Our research helps businesses make informed decisions by providing actionable data and trends. Technavio is based on four simple principles: easy-to-access reports, robust industry coverage, a focus on new and emerging technologies, and competitive pricing. We believe in helping companies and executives become better equipped to make faster, sounder, and more effective decisions. Technavio is one of the most influential market research and advisory firms in the world. We work with business and technology leaders to provide cutting-edge market research and insights to companies. 

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!
Technavio